Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de David V. Goeddel
Leeftijd : 68
Vermogen : 3 509 300 USD
Belangrijkste bedrijven : Tenaya Therapeutics, Inc. - NGM Biopharmaceuticals, Inc. - Peloton Therapeutics, Inc.
Overzicht 
Founder of Tularik, Inc. and Nurix Therapeutics, Inc., David V. Goeddel is a businessperson who has been at the helm of 9 different companies and presently holds the position of Chairman for Hexagon Bio, Inc., Chairman of A2 Biotherapeutics, Inc., Chairman for Tenaya Therapeutics, Inc., Managing Partner at The Column Group LLC, General Partner for Ponoi Capital LP and General Partner of Ponoi Capital II LP (both are subsidiaries of The Column Group LLC), Chairman of Peloton Therapeutics, Inc., Chairman for Surrozen Operating, Inc. and Chairman for Exonics Therapeutics, Inc. Dr. Goeddel is also on the board of NGM Biopharmaceuticals, Inc. (former Chairman), Neurona Therapeutics, Inc. and Nura Bio, Inc. and Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, General Partner at Ponoi Capital LP and General Partner of Ponoi Capital II LP.

In his past career he held the position of Chairman at Igenica Biotherapeutics, Inc., Senior Vice President-Scientific at Amgen, Inc. and Chief Executive Officer at Tularik, Inc. (a subsidiary of Amgen, Inc.), Director-Molecular Biology at Genentech, Inc. and Director at Nurix Therapeutics, Inc.

Dr. Goeddel received a doctorate from The University of Colorado and an undergraduate degree from the University of California San Diego.


Posities en verantwoordelijkheden van David V. Goeddel 
NaamTitel Van
Tenaya Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman 2016
NGM Biopharmaceuticals, Inc.
(Biotechnologie & Medisch Onderzoek)
Lead Independent Director 2018
Peloton Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman 2011
Hexagon Bio, Inc. Chairman 2020
Neurona Therapeutics, Inc. Director -
Surrozen Operating, Inc. Chairman -
Exonics Therapeutics, Inc. Chairman -
A2 Biotherapeutics, Inc. Chairman -
Nura Bio, Inc. Director -
National Academy of Sciences Member -
American Academy of Arts & Sciences Member -
The Column Group LLC Managing Partner 2007
Ponoi Capital LP General Partner -
Ponoi Capital II LP General Partner -


Belangnemingen van David V. Goeddel 
NaamAandelen%Totale waarde
NGM Biopharmaceuticals, Inc. (NGM)
(Biotechnologie & Medisch Onderzoek)
190 0000,25%3 509 300 USD


David V. GoeddelPersoonlijk netwerk 
Meest gelezen nieuws 
15/11PATRICK DRAHI : Altice-oprichter Drahi wil groter belang in BT - bronnen
MR
24/11ELON MUSK : Musk verkoopt Tesla-aandelen ter waarde van $1,05 mrd, koopt 2,15 mln aandelen
MR
24/11JAMIE DIMON : Jamie Dimon grapt dat JPMorgan langer meegaat dan de communistische partij van China
MR
17/11ELON MUSK : Tesla's Musk verkoopt nog eens 934.000 aandelen om belastingen te betalen na uitoefening opties - filing
MR
16/11ELON MUSK : Tesla's Musk verkocht 934.091 aandelen om aan belastingverplichtingen te voldoen - indiening
MR
24/11ERIK NORDSTROM : Nordstrom-winst blijft achter bij ramingen door problemen met bevoorrading, aandelen kelderen
MR
18/11MIUCCIA PRADA : Prada stelt 4,5 miljard euro omzetdoelstelling, om e-commerce te stimuleren
MR
23/11STUART ROSE : Morrisons aandeelhouders steunen CD&R's $10 mrd overname
MR
18/11JITSE GROEN : Lucas Bols straalt op lichtgroen Damrak
AM
17/11DAVID JONES : Zuid-Afrikaanse Woolworths kampt met 20% lagere halfjaarwinst door sluitingen in Australië
MR
Meer nieuws


© 2021 People and Ownership :   
David V. Goeddel Verbindingen